Youre eating less, your meals are smaller, and yet youre experiencing more acid reflux than before
CrossRef Research progress and frontier trends in liver cancer immunotherapy in the post-COVID-19 era (20202024): a visualization analysis based on bibliometric methods Shicai Liang, Xusheng Zhang, Xuebo Wang, Yannan Xie, Jialong Wang, Jiawei Wang, Bendong Chen Discover Oncology .2025;[Epub] CrossRef Serum Biomarkers for Hepatocellular Carcinoma: A Comparative Review of Traditional and Emerging Markers Min Kyung Park Journal of Digestive Cancer Research .2025
This month, The Conversations experts explore their rise, impact and potential consequences
Other reported effects included: Transient fatigue Reduced appetite (therapeutically desirable in the context of weight loss) Mild injection-site reactions Altered skin sensations or cutaneous hyperesthesia (reported in ~7% of participants, mild and non-serious) Serious adverse events were rare and occurred at similar rates in the retatrutide and placebo groups (approximately 4%)
Contact us today for more information or book in with one of our weight loss specialists at your earliest convenience
Additionally, semaglutide and tirzepatide stimulate the release of insulin from your pancreas and inhibit a hormone that triggers your liver to release excess sugar into the bloodstream
![PDF] Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial](https://figures.semanticscholar.org/a9800c8f0dc40d6d18a09ab6d2f14e71a42af380/8-Table2-1.png)
